_.gif)
_.gif)
Serum Interleukin-2 (IL-2) Levels in Untreated and Treated in Batak Tribe Patients with Schizophrenia
Abstract
To find out the difference of serum IL-2 levels between untreated and treated in the Batak tribe patients with schizophrenia and healthy control and also to find out the association between serum IL-2 levels with PANSS score in the Batak tribe patients with schizophrenia. This study was cross-sectional approach using a one-way ANOVA welch test and to find a correlation between serum IL-2 levels with PANSS score in the Batak tribe patients with schizophrenia which is conducted in Prof. Dr. M. Ildrem Psychiatric Hospital Medan and Dr. Pirngadi General Hospital Medan from September 2019-November 2019. Subjects of untreated were 55 subjects and treated in the Batak tribe patients with schizophrenia were 55 subjects and healthy control were 55 subjects. There were significant differences between these three groups using post hoc Games-Howell test on the value of p<0.001 and also been found there was a significant correlation between serum IL-2 levels with PANSS score in the Batak tribe patients with schizophrenia using the Pearson correlation test (r=0.599, p=0.001 and r=0.501, p=0.001). It was founded that there were significant differences between serum IL-2 levels in three groups and also founded there was a significant correlation between serum IL-2 levels with PANSS score in the Batak tribe patients with schizophrenia.
Keywords
Full Text:
PDFReferences
Sadock BJ, Sadock VA, Ruiz P. Schizophrenia. In Sadock BJ, Sadock VA, Ruiz P, editors. Kaplan & Sadock's Synopsis of Psychiatry Behavioral Sciences/Clinical Psychiatry, 10th Edition. Tenth Edition ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 465-497.
Reale M, Patruno A, Lutiis MAD, Pesce M, Felaco M, Di Giannantonio M, et al. Dysregulation of Chemo-Cytokine Production in Schizophrenic Patients Versus Healthy Controls. BMC Neuroscience. 2011; 12(13): p. 1-9.
Paul-Samojedny M, Owczarek A, Kowalczyk M, Suchanek R, Palacz M, Kucia K, et al. Association of Interleukin 2 (IL-2), Interleukin 6 (IL-6), dan TNF-Alpha (TNF-α) Gene Polymorphisms With Paranoid Schizophrenia In A Polish Population. The Journal of Neuropsychiatry and Clinical Neurosciences. 2013; 25: p. 72-82.
Upthegrove R, Barnes NM. The Immune System and Schizophrenia: an Update For Clinicians. Advances in Psychiatric Treatment. 2014. 20: p. 83-91. doi: 10.1192/apt.bp.113.011452.
Na KS, Jung HY, Kim YK. The Role of Pro-Inflammatory Cytokines in The Neuroinflammation and Neurogenesis of Schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2012; 48: p. 277-286.
Kim YK, Kim L, Lee MS. Relationships Between Interleukins, Neurotransmitters, and Psychopathology in Drug-Free Male Schizophrenia. Schizophrenia Research. 2000; p. 165-175.
Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC. Changes in Serum Interleukin-2, -6 and -8 Levels Before and During Treatment With Risperidone and Haloperidol: Relationship to Outcome in Schizophrenia. J Clin Psychiatry. 2004; 65: p. 940-947.
Tan Y, Li Y, Tan S, Wang Z, Yang FD, Cao B, Zunta-Soares GB, Soares JC, Zhang XY. Increased Interleukin-2 Serum Levels Were Associated with Psychopathological Symptoms and Cognitive Deficits in Treatment-Resistant Schizophrenia. Schizophrenia Research. 2015. http://dx.doi.org/10.1016/j.schres.2015.10.038.
Sastroasmoro S, Ismail S. Dasar-dasar Metodologi Penelitian Klinis. Edisi Ketiga. Jakarta. Sagung Seto. 2008.
Marder SR, Davis MC. Second-Generation Antipsychotic. In Sadock BJ, Sadock VA, Ruiz P, Editors. Kaplan & Sadock’s Comprehensive Textbook of Psychiatry. Vol. I. 10th Ed. Philadelphia: Lippincott Williams & Wilkinsi. 2017. p. 8104-8229.
Stahl SM. Essential Psychopharmacology Prescriber’s Guide. Cambridge University Press. 6th Ed. New York. 2017. p. 627-653.
Dahlan MS. Besar Sampel Dalam Penelitian Kedokteran dan Kesehatan. Jakarta. Epidemiologi Indonesia. 2019.
Dahlan M Sopiyudin. Langkah-Langkah Membuat Proposal Penelitian Bidang Kedokteran Dan Kesehatan. Jakarta. Sagung Seto. 2014.
Dahlan MS. Statistik Untuk Kedokteran Dan Kesehatan. Jakarta: Epidemiologi Indonesia. 2014.
Sadock BJ, Sadock VA. Ruiz P. Schizophrenia Spectrum and Other Psychotic Disorder. In Kaplan & Sadock's Synopsis of Psychiatry Behavioral Sciences/Clinical Psychiatry, 11th Edition. Philadelphia: Lippincott Williams & Wilkins; 2015. p. 300-323.
Pinho LG, Pereira A, Chaves C. Influence of Sociodemographic and Clinical Characteristics on The Quality of Life of Patients With Schizophrenia. Rev Esc Enferon USP. 2017; 51 : p. 1-7.
Huang J, Chiovenda A, Shao Y, Ma H, Li H, Jo Delvecchio, Good M. Low Level of Knowledge Regarding Diagnosis and Treatment Among Inpatients with Schizophrenia in Shanghai. Neuropsychiatric Disease and Treatment. 2018 January; 14(1): p. 185-191.
Bowmans C, Sonnevile CD, Mulder CL, Van Roijen LH. Employment and The Associated Impact on Quality of Life in People Diagnosed With Schizophrenia. Neuropsychiatric Disease and Treatment. 2015; 11: p. 2125-2214.
Juncal-Ruiz M, Riesco-Davila L, Ortiz-Garcia de la Foz V, Ramirez-Bonilla M. The Effect of Excess Weight on Circulating Inflammatory Cytokines in Drug Naïve First Episode Psychosis Individuals. Juncal-Ruiz et al. Journal of Neuroinflammation. 2018; 15 (63): p. 1-8.
Ajami A, Abedian F, Hosseini SH, Akbarian E, Alizadeh-Navaei R, Taghipour M. Serum TNF-ά, IL-10 and IL-2 in Schizophrenic Patients Before and After Treatment with Risperidone and Clozapine. Iran Journal Immunology; 2014. 11(3): p. 200-209.
DOI: https://doi.org/10.33258/birci.v4i1.1773
Article Metrics
Abstract view : 154 timesPDF - 105 times
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.